Peptides 1994
DOI: 10.1007/978-94-011-0683-2_227
|View full text |Cite
|
Sign up to set email alerts
|

Chimeric amino acids in cyclic bradykinin analogs: Evidence for receptor-bound turn conformation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
15
0

Year Published

1998
1998
2005
2005

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 6 publications
0
15
0
Order By: Relevance
“…Different conformational shapes for BK agonists have been proposed as a result of these investigations, e.g. random conformations (37,38), quasicyclic structures (34,39), turned structures at the N‐terminus (40), in the middle of the molecule (41,42) or at the C‐terminus (43–45). Studies with BK antagonists have suggested turned structures, in the N‐terminal sequence (between positions 2 and 5) (46,47), the C‐terminal sequence (between positions 6 and 9) (33,48,49) or in both fragments (32,35,36).…”
mentioning
confidence: 99%
“…Different conformational shapes for BK agonists have been proposed as a result of these investigations, e.g. random conformations (37,38), quasicyclic structures (34,39), turned structures at the N‐terminus (40), in the middle of the molecule (41,42) or at the C‐terminus (43–45). Studies with BK antagonists have suggested turned structures, in the N‐terminal sequence (between positions 2 and 5) (46,47), the C‐terminal sequence (between positions 6 and 9) (33,48,49) or in both fragments (32,35,36).…”
mentioning
confidence: 99%
“…13 C-NMR (CDCl 3 ) δ 169. 7,145.9,134.5,131.8,129.0,128.3,126.1,125.3,124.4,73.0,62.1,51.5,48.8,40.7,30.7,29.4. Anal.…”
Section: Methyl 1-benzamido-t-4-o-mesyl-t-2-(thien-2-yl)cyclohexane-rmentioning
confidence: 99%
“…2,3 Several β-substituted prolines ( Figure 1) have been synthesized as amino acid chimeras in which the functional groups of the amino acid side-chain are combined with the conformational restrictions characteristic of the cyclic amino acid residue. 4 Replacement of the natural amino acids in peptides with such proline-α-amino acid chimeras has led to better understanding of the bioactive conformations of cholecystokinin, 5 angiotensin II, 6 bradykinin, 7 and opioid peptides. 8,9 Also, β-alkylproline analogues have served for the development of enzyme inhibitors, 9,10 as well as peptidomimetics exhibiting improved bioactivity and greater metabolic stability.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1 Replacement of the natural amino acids in peptides for such proline-a-amino acid chimeras has led to a better understanding of the bioactive conformations. [2][3][4][5][6][7][8][9][10] Additionally, b-alkylproline analogues have served for the development of enzyme inhibitors, 11,12 as well as peptidomimetics exhibiting improved bioactivity and greater metabolic stability. 5,12 We are currently involved in a research project devoted to determining the conformational preferences of constrained analogues of proteinogenic amino acids when incorporated into a peptide chain.…”
Section: Introductionmentioning
confidence: 99%